REZANT Trademark

Trademark Overview


On Wednesday, February 5, 2020, a trademark application was filed for REZANT with the United States Patent and Trademark Office. The USPTO has given the REZANT trademark a serial number of 79282110. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 2, 2023. This trademark is owned by NOVARTIS AG. The REZANT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
rezant

General Information


Serial Number79282110
Word MarkREZANT
Filing DateWednesday, February 5, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 2, 2023
Registration Number6121514
Registration DateTuesday, August 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Saturday, September 16, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, September 16, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 17, 2020NOTIFICATION PROCESSED BY IB
Thursday, October 1, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 1, 2020FINAL DISPOSITION PROCESSED
Thursday, September 10, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020NOTICE OF PUBLICATION
Monday, April 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2020ASSIGNED TO EXAMINER
Tuesday, April 7, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, April 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 30, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 26, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB